CClinicalTrials.gg
RecruitingNCT07379606Updated Aug 3, 2026

Effects of Moderate Exercise and Cyclic Sighing on Stress, Cognition and Physiological Markers in Young Adults

An interventional study of Moderate-Intensity Physical Activity (PA) and Breathing Training - Cyclic Sighing (CS) in Stress, sponsored by Poznan University of Physical Education. Recruiting at 1 site in Poland. Open to participants aged 18 Years to 35 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by Poznan University of Physical Education · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Started Jul 2026; still recruiting 2 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years to 35 Years
Sex
All
01

Study summary

This study investigates the effects of moderate physical exercise and cyclic sighing (breathing training) on stress, cognition, and physiological markers in young adults. It is a randomized cross-over trial with two interventions. Each participant will take part in two intervention sessions:

  1. Moderate-intensity physical activity (PA): 15 minutes of stationary cycling at 65-75% of maximum heart rate (HRmax).
  2. Breathing training (CS): 15 minutes of cyclic sighing, a technique involving inhaling, pausing briefly, taking a deeper breath, and exhaling slowly.

A one-week washout period between sessions is planned to minimise carry-over effects and to ensure participants' physiological state is similar before the next session. During this week, participants will wear Polar Ignite wrist-worn devices to monitor physical activity and sleep.

A total of 30 participants (you adults) will be enrolled.

Measurements performed before and after each intervention include:

  • EEG using Emotiv EPOC Flex Gel (32-channel device): 2 minutes with eyes open, 2 minutes with eyes closed, during the interventions, and while performing cognitive test (N-back).
  • Heart rate variability (HRV) using the Polar H10 sensor.
  • SUDS - Subjective Units of Disress Scale for perceived stress.
  • N-back test for cognitive performance using Emotiv App.
  • Blood pressure (systolic and diastolic) and heart rate.
  • Pain threshold measured with a dolorimeter.
  • PANAS-SF - Positive and Negative Affect Schedule.

Baseline questionnaires completed by participants the day before the study:

  • PSS-10 - Perceived Stress Scale (Cohen, Kamarck, Mermelstein).
  • MAAS - Mindful Attention Awareness Scale
  • Psychological well-being - short version
  • Mini-COPE - Coping with Stress Inventory
  • Sleep quality and average sleep duration
  • Chronotype questionnaire (morningness-eveningness)
  • GPAQ - Global Physical Activity Questionnaire
  • Pittsburgh Sleep Quality Index

The study aims to understand how brief interventions like moderate exercise and breathing techniques affect stress, cognitive performance, and physiological responses in young adults.

02

Conditions studied

  • Stress
03

In context

Lead sponsor

Poznan University of Physical Education is the lead sponsor of 90 studies on the registry; 27 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 35 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • male or female participants,
  • age 18-35,
  • without chronic somatic diseases,
  • no current episode of psychiatric disorder (no active depression, mania, or psychosis),
  • regular sleep schedule in the week prior to the study,
  • not taking psychotropic drugs or medications,
  • non-smoker,
  • not working nightshifts.

Exclusion criteria

Exclusion Criteria:

  • consumption of alcohol or psychoactive substances the day before or on the day of the study,
  • intense physical activity less than 2 hours before the study,
  • consuming coffee, black tee, energy drinks less than 2 hours before the study,
  • contraindications to moderate-intensity physical activity on cycle ergometer (e.g., recent injuries),
  • contraindications to EEG (e.g., scalp skin conditions preventing proper electrode placement, hypersensitivity to conductive gels or pastes).
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Moderate-Intensity Physical Activity (PA)

    Participants perform 15 minutes of stationary cycling at moderate intensity.

    Behavioral: Moderate-Intensity Physical Activity (PA)

  • Experimental
    Breathing Training - Cyclic Sighing (CS)

    Participants perform 15 minutes of cyclic sighing.

    Behavioral: Breathing Training - Cyclic Sighing (CS)

Interventions

  • BehavioralModerate-Intensity Physical Activity (PA)

    Participants perform 15 minutes of stationary cycling at moderate intensity.

  • BehavioralBreathing Training - Cyclic Sighing (CS)

    Participants perform 15 minutes of cyclic sighing (a breathing technique).

06

What researchers measure

Primary outcomes

  1. Mean EEG spectral power in theta, alpha, low beta, high beta, gamma frequency bands during resting-state (eyes-open and eyes-closed)

    Mean spectral power in theta, alpha, low beta, high beta, and gamma frequency bands derived from resting-state EEG recordings collected during eyes-open and eyes-closed conditions. Spectral power will be calculated separately for eyes-open and eyes-closed resting-state conditions.

    Time frame: Baseline: immediately before intervention; Post-intervention: immediately after completion of the intervention period

  2. Heart Rate Variability (HRV)

    HRV will be recorded at three time points. Baseline HRV will be calculated as the average over a 5-minute resting-state period immediately before intervention. HRV during the intervention will be calculated as the average over the entire intervention session (periprocedural). Post-intervention HRV will be calculated as the average over a 5-minute resting-state period immediately after intervention.

    Time frame: Baseline (average over 5-minute resting-state immediately before intervention); During intervention (average over entire session, periprocedural); Post-intervention (average over 5-minute resting-state immediately after intervention).

Secondary outcomes

  1. Mean EEG spectral power in theta, alpha, low beta, high beta, and gamma frequency bands during N-back task

    Mean spectral power in theta, alpha, low beta, high beta, and gamma frequency bands derived from EEG recordings collected during performance of the N-back cognitive task. Spectral power will be calculated separately for each frequency band and averaged across all EEG channels.

    Time frame: Baseline (during N-back task immediately before each intervention session, periprocedural); Post-intervention (during N-back task immediately after each intervention session, periprocedural)

  2. Mean EEG spectral power in theta, alpha, low beta, high beta, and gamma frequency bands during intervention session

    Mean spectral power in theta, alpha, low beta, high beta, and gamma frequency bands derived from EEG recordings collected during the intervention session. Spectral power will be calculated separately for each frequency band and averaged across all EEG channels.

    Time frame: During intervention session (periprocedural, averaged over entire session)

  3. Perceived Stress measured with the Subjective Units of Distress Scale (SUDS)

    Participants rate their perceived stress using the Subjective Units of Distress Scale (SUDS), a self-reported scale ranging from 0 (no stress) to 100 (extreme stress), where higher scores indicate higher perceived stress.

    Time frame: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  4. Cognitive Performance (N-back)

    Working memory assessed using N-back test with Emotiv app.

    Time frame: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  5. Blood Pressure

    Systolic and diastolic blood pressure measured using standard protocols.

    Time frame: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  6. Pain Threshold

    Pain threshold measured using a dolorimeter (algorimeter)

    Time frame: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  7. Positive and Negative Affect measured with the Positive and Negative Affect Schedule - Short Form (PANAS-SF)

    Participants complete the Positive and Negative Affect Schedule - Short Form (PANAS-SF), a self-reported scale assessing positive and negative affect. Each subscale contains 10 items rated from 1 (very slightly or not at all) to 5 (extremely), giving a possible score range of 10-50 for each subscale. Higher scores indicate higher levels of positive or negative affect, depending on the subscale.

    Time frame: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

  8. Heart Rate

    Heart rate measured using standard protocols.

    Time frame: Baseline: immediately before each intervention session; Post-intervention: immediately after each intervention session

Other outcomes

  1. Psychological Well-Being measured with the Short Version of Ryff's Psychological Well-Being Scale

    Participants complete the Short Version of Ryff's Psychological Well-Being Scale, a self-reported questionnaire assessing psychological well-being across multiple dimensions. Items are rated on a scale from 1 (strongly disagree) to 6 (strongly agree), giving a total possible score range of 18-108, where higher scores indicate higher levels of psychological well-being.

    Time frame: Day before first intervention.

  2. Trait Mindfulness measured with the Mindful Attention Awareness Scale (MAAS)

    Participants complete the Mindful Attention Awareness Scale (MAAS), a self-reported questionnaire measuring trait mindfulness. Items are rated on a scale from 1 (almost always) to 6 (almost never), with total scores ranging from 15 to 90. Higher scores indicate higher levels of trait mindfulness.

    Time frame: Day before first intervention.

  3. Coping with Stress measured with the Brief COPE Inventory (mini-COPE)

    Participants complete the Brief COPE Inventory (mini-COPE), a self-reported questionnaire assessing coping strategies and stress management. Each item is rated on a scale from 1 (I haven't been doing this at all) to 4 (I've been doing this a lot), with total subscale scores ranging from 2 to 8, depending on the subscale. Higher scores indicate greater use of the specific coping strategy.

    Time frame: Day before first intervention.

  4. Chronotype measured with the Morningness-Eveningness Questionnaire (MEQ)

    Participants complete the Morningness-Eveningness Questionnaire (MEQ) to assess chronotype, indicating morningness-eveningness preference. Items are scored to give a total score ranging from 16 to 86, where higher scores indicate greater morningness and lower scores indicate greater eveningness.

    Time frame: Day before first intervention.

  5. Global Physical Activity measured with the Global Physical Activity Questionnaire (GPAQ)

    Participants complete the Global Physical Activity Questionnaire (GPAQ) to assess baseline physical activity levels. Responses are used to calculate total physical activity expressed in MET-minutes per week, with higher scores indicating higher levels of physical activity.

    Time frame: Day before first session.

  6. Sleep Quality and Duration (Pittsburgh Sleep Quality Index)

    Participants complete the Pittsburgh Sleep Quality Index (PSQI) to assess sleep quality and average sleep duration.

    Time frame: Day before first session.

  7. Objective Sleep and Physical Activity (Polar Ignite)

    Participants wear Polar Ignite wrist-worn devices to monitor sleep quality and duration, as well as daily physical activity levels.

    Time frame: During the 1-week washout period between intervention sessions.

07

Study locations

1 of 1 sites recruiting
  • Poznan University of Physical Education
    Poznan, Wielkopolska 61-871, Poland
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — De-identified individual participant data (IPD) will be shared in the RepOD repository after study completion. An embargo of up to 36 months may apply to allow for publication of primary study results. Data will be available for scientific research purposes.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07379606
Lead sponsor
Poznan University of Physical Education
Responsible party
Sponsor
First posted
Jan 30, 2026
Start date
Jul 31, 2026
Primary completion
Oct 30, 2026 (estimated)
Completion
Oct 30, 2026 (estimated)
Last update
Aug 3, 2026

Study contacts

Beata Jóźwiak
Contact
b.jozwiak@awf.poznan.pl
(61) 835 53 49
Ida Laudańska-Krzemińska
study director · Poznan University of Physical Education

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion